Think the FDA will probably ask for another trial in that subset. Another question/problem is what will it take to find early AD patients - PIB brain imaging? CSF phoshpo-Tau levels? these tests carry logistic and economic implications.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.